Dr. Priyanka Banerjee earned her Ph.D. in Biochemistry (Molecular Biology) from India. She has more than 15 years of experience in Molecular Biology, Cancer biology, and is currently working working on metastatic cancer progression, cellular crosstalk in tumor microenvironment in her role as postdoctoral research associate in US lab.
Dr. Banerjee has extensive experience reviewing for multiple journals (more than 25 journals), and has published her own work in peer reviewed journals, including, Cancer Immunology Research, Redox Biology, Scientific Reports, Journal of Clinical Microbiology, Clinical Microbiology and Infection etc.
I'm currently a Senior Research Scientist in the Physiology & Health Team at AgResearch Limited, one of New Zealand's Crown Research Institutes (CRIs). I'm based at the University of Auckland's Liggins Institute, being involved in several projects investigating the importance of nutrition for health throughout life. The primary focus of these projects is intestinal health, but I'm also interested other aspects of human health, including cognition and mobility.
I graduated from The University of Auckland in May 2005 with a PhD in Biological Sciences. My thesis research focused on the importance of a mother’s diet during gestation and lactation on the risk of type-2 diabetes in her offspring. Since 2001 I've worked for AgResearch in a range of roles (including Research Associate, FRST Postdoctoral Fellow, and Research Scientist) and on a variety of topics. I was part of the Nutrigenomics New Zealand collaboration from 2004-2014, working on understanding how our diet and genome interact to influence health with a particular focus on intestinal function.
I was the Section Editor (Nutrigenomics) for the European Journal of Nutrition from 2014 to 2019.
Davide Barreca is an Associate Professor of biochemistry at the University of Messina. He is specialized in enzyme modulation by natural compounds, inhibition of protein aggregation and activation of signal apoptotic cascade. Most of his research projects concentrate on separation and identification of unknown flavonoids, structural-activity elucidation, and biochemical analysis of their health promoting or cytotoxicity properties on cells culture. He is author of over 110 papers in peer-reviewed journals, 35 chapters in books, and 70 conference proceedings and reviewer of over 40 international scientific journals.
Executive Director (Head) of the Institute fof Molecular Physiology and Biotechnology of Plants (IMBIO) at the Universtiy of Bonn. Editor in Chief of Planta. Member of EMBO
Professor in the School of Biological Sciences, University of Western Australia. I hold an Australian Research Council Future Fellowship. Research interests include plant-pathogen interactions, crop genetics and genomics, genome sequencing, Brassicas, structural variation, diversity genomics, methylation
Prof. Travis Beddoe is a multidisciplinary scientist, training initially as a plant biochemist before studying molecular chaperones in mitochondrial targeting as a PhD student (awarded March 2004), and eventually training in biophysical and structural biology in immune receptors as a postdoctoral researcher. He started his independent research career at Monash University with an NHMRC CDA fellowship (2008) followed by a Pfizer Australia Research fellowship (2010) in the area of glycan specificity in bacterial pathogenesis and physiology. Dr. Beddoe changed research fields when he was recruited to La Trobe University in 2014 as a senior lecturer to establish a laboratory focused on livestock-pathogen interactions in the School of Animal, Plant and Soil Science located in the AgriBio centre. His research is concentrated on aiding animal health with a focus on field-based diagnostics, molecular understanding of the role glycans and glycan-binding proteins play in disease pathogenesis and vaccine development.
Professor of Biology at the University of Antwerp. Member of the Flemish Science Foundation review board. Editor of the journals Journal of Plant Research, Frontiers in Plant Science and PLOS ONE
Dr. Berghout received her PhD in Biochemistry from McGill University in Montreal, QC where she researched the genetics of complex traits and susceptibility to infectious disease in humans and mouse models. Following that, she spent three years as the Outreach Coordinator for the Mouse Genome Informatics (MGI) database in Bar Harbor, ME. There, she trained researchers in genetics, genomics, data structures and data mining to answer biological questions, and worked closely with other members of the MGI group to develop and optimize the MGI resource. Now her research interests include genetics of all kinds, personalized medicine, big data, and scientific communication. She is currently pursuing projects in precision medicine for analysis of transcriptome data from patients with rare lung diseases (Sarcoidosis, Coccidiomycosis), and integrative network analysis of complex traits including Alzheimer's Disease. She is currently appointed at the University of Arizona's Center for Biomedical Informatics and Biostatistics (CB2) and The Center for Genetics and Genomic Medicine (TCG2M) in Tucson, AZ.
Regental Professor and Director of the Center for the Genetics of Host Defense at the UT Southwestern Medical Center in Dallas, Texas. Member of the National Academy of Sciences and the Institute of Medicine. Recipient of many awards, including the 2011 Nobel Prize for Medicine; the 2011 Shaw Prize; the 2009 Will Rogers Institute Annual Prize; the 2009 Albany Medical Center Prize; the 2007 Balzan Prize and the 2004 Robert Koch Prize. (Photo by Brian Coats for UT Southwestern Med Ctr)
Dr. Rajesh Bhardwaj is a senior research fellow at the National Institute of Environmental Health Sciences in North Carolina, USA. He is skilled in combining molecular and structural biology techniques as well as pharmacological and computational approaches with state-of-the-art high-throughput screening to dissect the gating and regulatory molecular mechanisms of calcium channels, calcium sensors and solute carrier family transporters. His research interests include studying calcium signaling in health and disease with a focus on the endoplasmic reticulum membrane contact sites with plasma membrane and mitochondria.
I graduated at the University of Milan and obtained my PhD (Molecular and Cell Biology) degree while working at the FIRC Institute for Molecular Oncology (Milan, Italy) and then at Oxford University (Oxford, UK). I worked as postdoctoral fellow in Pier Paolo Di Fiore’s lab at IFOM, Milan, and then at the Program of Molecular Medicine of the European Institute of Oncology (Milan, Italy). Since 2016, I am the Head of the Cancer Biomarkers Unit at the Institute for Regenerative Medicine (ISBReMIT) at Casa Sollievo della Sofferenza-IRCCS. I have several years of research experience in the field of cancer genomics and biomarkers development, particularly in the field of circulating miRNAs, cancer gene expression profile and computational biology. I have contributed to the identification of a serum circulating miRNA-signature for early detection of lung cancer, which was patented and transferred to a SME. I am an inventor in international patents regarding diagnostic and prognostic tools for lung cancer screening (US8747867B2; US20150057159A1; US20160068913A1). I am an active member of the American Association for Cancer Research (AACR), the European Association for Cancer Research (EACR), the International Association for the Study of Lung Cancer (IASLC) and the Italian Society for Cancer Research (SIC) where I hold the position of secretary and member of director board.
Group Leader at The Francis Crick Institute from April 2015. Programme Leader and Wellcome Trust Career Development Fellow at National Institute for Medical Research in London, UK from end of 2008. Previously, Royal Society Dorothy Hodgkin Fellow at King’s College London.
Kate Bishop received a first class (hon) BSc in Biochemistry from the University of Bath following two research placements; one at the Karolinska Institute in Stockholm, Sweden and the other at Chiron Corporation in San Francisco, USA.
After completing her PhD studies with Jonathan Stoye working on the retroviral restriction factor, Fv1, she undertook postdoctoral training with Michael Malim at King's College London, investigating the APOBEC family of retroviral restriction factors.
Kate was awarded a prestigious Royal Society Dorothy Hodgkin Fellowship in 2004 to continue her APOBEC research.